Nanocarrier‐mediated FABP5 deletion was found to promote RFA‐induced ferroptosis and anti‐tumor immune responses, including increased infiltration of CD8+ T cells and effector memory T cells, through activation of the STING/TBK1 pathway and stabilization of TBK1 protein. The gene discussed is FABP5; the disease is neoplasm.